Two drug injury-related deaths lead Pfizer to recall drug
December 16, 2010
The U.S. Food and Drug Administration and drug manufacturers try to ensure the safety of drugs before putting them on the market. Unfortunately, studies before the market availability of the drugs don’t always indicate potential drug injuries or side effects.
That may be the case with a current drug recall. According to Reuters, Pfizer is recalling the lung drug Thelin after two patient deaths have allegedly been connected to the drug.
Thelin could lead to drug injuries such as deadly liver toxicity.
Fatal liver injuries were said to be the causes of death for the two patients who suffered drug injuries.